chr3-119628713-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_015900.4(PLA1A):āc.1134A>Gā(p.Gln378Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00981 in 1,614,028 control chromosomes in the GnomAD database, including 97 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0065 ( 3 hom., cov: 32)
Exomes š: 0.010 ( 94 hom. )
Consequence
PLA1A
NM_015900.4 synonymous
NM_015900.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0620
Genes affected
PLA1A (HGNC:17661): (phospholipase A1 member A) The protein encoded by this gene is a phospholipase that hydrolyzes fatty acids at the sn-1 position of phosphatidylserine and 1-acyl-2-lysophosphatidylserine. This secreted protein hydrolyzes phosphatidylserine in liposomes. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 3-119628713-A-G is Benign according to our data. Variant chr3-119628713-A-G is described in ClinVar as [Benign]. Clinvar id is 790979.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.062 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLA1A | NM_015900.4 | c.1134A>G | p.Gln378Gln | synonymous_variant | 10/11 | ENST00000273371.9 | NP_056984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLA1A | ENST00000273371.9 | c.1134A>G | p.Gln378Gln | synonymous_variant | 10/11 | 1 | NM_015900.4 | ENSP00000273371.4 | ||
PLA1A | ENST00000494440.5 | c.1086A>G | p.Gln362Gln | synonymous_variant | 10/11 | 1 | ENSP00000418793.1 | |||
PLA1A | ENST00000495992.5 | c.1086A>G | p.Gln362Gln | synonymous_variant | 10/11 | 1 | ENSP00000417326.1 | |||
PLA1A | ENST00000488919.5 | c.615A>G | p.Gln205Gln | synonymous_variant | 9/10 | 2 | ENSP00000420625.1 |
Frequencies
GnomAD3 genomes AF: 0.00646 AC: 983AN: 152204Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
983
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00667 AC: 1676AN: 251248Hom.: 11 AF XY: 0.00658 AC XY: 894AN XY: 135792
GnomAD3 exomes
AF:
AC:
1676
AN:
251248
Hom.:
AF XY:
AC XY:
894
AN XY:
135792
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0102 AC: 14854AN: 1461706Hom.: 94 Cov.: 31 AF XY: 0.00973 AC XY: 7077AN XY: 727162
GnomAD4 exome
AF:
AC:
14854
AN:
1461706
Hom.:
Cov.:
31
AF XY:
AC XY:
7077
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00645 AC: 983AN: 152322Hom.: 3 Cov.: 32 AF XY: 0.00559 AC XY: 416AN XY: 74482
GnomAD4 genome
AF:
AC:
983
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
416
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at